Advertisement

Radiation Therapy in Craniopharyngioma

  • C. Seidel
  • J. Meixensberger
  • R. -D. Kortmann
Living reference work entry

Abstract

Craniopharyngioma are rare intracranial, perisellar tumors of adamantinomatous or papillary subtype. Alhough “benign” in nature they might lead to devastating deficits or death in children or adults. After surgical resection local failure occurs frequently. Definitive/adjuvant radiation therapy or treatment at relapse yields high local control rates and long overall survival. Radicality of resection and timing of radiotherapy must be balanced against side effects. Fractionated intensity modulated radiotherapy (IMRT) and fractionated stereotactic radiotherapy or proton-treatment are preferential radiation techniques.

Keywords

Craniopharyngioma Sellar tumors Radiotherapy 

References

  1. Adamson TE, Wiestler OD, Kleihues P, Yaşargil MG. Correlation of clinical and pathological features in surgically treated craniopharyngiomas. J Neurosurg. 1990;73:12–7.CrossRefPubMedGoogle Scholar
  2. Aggarwal A, Fersht N, Brada M. Radiotherapy for craniopharyngioma. Pituitary. 2013;16:26–33.CrossRefPubMedGoogle Scholar
  3. Astradsson A, Munck Af Rosenschöld P, Feldt-Rasmussen U, Poulsgaard L, Wiencke AK, Ohlhues L, Engelholm SA, Broholm H, Hansen Møller E, Klose M, et al. Visual outcome, endocrine function and tumor control after fractionated stereotactic radiation therapy of craniopharyngiomas in adults: findings in a prospective cohort. Acta Oncol. 2017;56:415–21.CrossRefPubMedGoogle Scholar
  4. Beltran C, Roca M, Merchant TE. On the benefits and risks of proton therapy in pediatric craniopharyngioma. Int J Radiat Oncol Biol Phys. 2012;82:e281–7.CrossRefPubMedGoogle Scholar
  5. Bishop AJ, Greenfield B, Mahajan A, Paulino AC, Okcu MF, Allen PK, Chintagumpala M, Kahalley LS, McAleer MF, McGovern SL, et al. Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity. Int J Radiat Oncol Biol Phys. 2014;90:354–61.CrossRefPubMedPubMedCentralGoogle Scholar
  6. Brastianos PK, Taylor-Weiner A, Manley PE, Jones RT, Dias-Santagata D, Thorner AR, Lawrence MS, Rodriguez FJ, Bernardo LA, Schubert L, et al. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet. 2014;46(2):161–5.CrossRefPubMedPubMedCentralGoogle Scholar
  7. Brastianos PK, Shankar GM, Gill CM, Taylor-Weiner A, Nayyar N, Panka DJ, Sullivan RJ, Frederick DT, Abedalthagafi M, Jones PS, et al. Dramatic response of BRAF V600E mutant papillary craniopharyngioma to targeted therapy. J Natl Cancer Inst. 2016;108(2).CrossRefPubMedPubMedCentralGoogle Scholar
  8. Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. J Neurosurg. 1998;89:547–51.CrossRefPubMedGoogle Scholar
  9. Buslei R, Nolde M, Hofmann B, Meissner S, Eyupoglu IY, Siebzehnrübl F, Hahnen E, Kreutzer J, Fahlbusch R. Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol. 2005;109:589–97.CrossRefPubMedGoogle Scholar
  10. Cavallo LM, Solari D, Esposito F, Villa A, Minniti G, Cappabianca P. The role of the endoscopic endonasal route in the management of craniopharyngiomas. World Neurosurg. 2014;82:S32–40.CrossRefPubMedGoogle Scholar
  11. Combs SE, Thilmann C, Huber PE, Hoess A, Debus J, Schulz-Ertner D. Stephanie E. Combs, Christoph Thilmann, Peter E. Huber, Angelika Hoess, Jürgen Debus, Daniela Schulz-Ertner, Achievement of long-term. local control in patients with craniopharyngiomas using high precision stereotactic radiotherapy. Cancer. 2007;109 (11):2308–2314.CrossRefPubMedGoogle Scholar
  12. Dandurand C, Sepehry AA, Asadi Lari MH, Akagami R, Gooderham P. Adult craniopharyngioma: case series, systematic review, and meta-analysis. Neurosurgery. 2017;0:0–11.Google Scholar
  13. Dhandapani S, Singh H, Negm HM, Cohen S, Souweidane MM, Greenfield JP, Anand VK, Schwartz TH. Endonasal endoscopic reoperation for residual or recurrent craniopharyngiomas. J Neurosurg. 2017;126:418–30.CrossRefPubMedGoogle Scholar
  14. Elliott RE, Wisoff JH, Successful surgical treatment of craniopharyngioma in very young children. Journal of Neurosurgery: Pediatrics 3. 2009;(5):397–406.PubMedGoogle Scholar
  15. Fitzek MM, Linggood RM, Adams J, Munzenrider JE. Combined proton and photon irradiation for craniopharyngioma: long-term results of the early cohort of patients treated at Harvard Cyclotron Laboratory and Massachusetts General Hospital. Int J Radiat Oncol Biol Phys. 2006;64:1348–54.CrossRefPubMedGoogle Scholar
  16. Greenfield BJ, Okcu MF, Baxter PA, Chintagumpala M, Teh BS, Dauser RC, Su J, Desai SS, Paulino AC. Long-term disease control and toxicity outcomes following surgery and intensity modulated radiation therapy (IMRT) in pediatric craniopharyngioma. Radiother Oncol. 2015;114:224–9.CrossRefPubMedGoogle Scholar
  17. Harrabi SB, Adeberg S, Welzel T, Rieken S, Habermehl D, Debus J, Combs SE, Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects. Radiation Oncology. 2014;9 (1):203.CrossRefPubMedGoogle Scholar
  18. Hashizume C, Mori Y, Kobayashi T, Shibamoto Y, Nagai A, Hayashi N, Stereotactic radiotherapy using Novalis for craniopharyngioma adjacent to optic pathways. Journal of Neuro-Oncology. 2010;98 (2):239–247.CrossRefPubMedGoogle Scholar
  19. Hetelekidis S, Barnes PD, Tao ML, Fischer EG, Schneider L, Scott RM, Tarbell NJ. 20-year experience in childhood craniopharyngioma. Int J Radiat Oncol Biol Phys. 1993;27:189–95.CrossRefPubMedGoogle Scholar
  20. Hoffmann A, Warmth-Metz M, Gebhardt U, Pietsch T, Pohl F, Kortmann R-D, Calaminus G, Müller HL. Childhood craniopharyngioma – changes of treatment strategies in the trials KRANIOPHARYNGEOM 2000/2007. Klin Padiatr. 2014;226:161–8.CrossRefPubMedGoogle Scholar
  21. Jeon C, Kim S, Shin HJ, Nam D-H, Lee J-I, Park K, Kim JH, Jeon B, Kong D-S. The therapeutic efficacy of fractionated radiotherapy and gamma-knife radiosurgery for craniopharyngiomas. J Clin Neurosci. 2011;18:1621–5.CrossRefPubMedGoogle Scholar
  22. Kanesaka N, Mikami R, Nakayama H, Nogi S, Yu T, Nakajima N, Wada J, Miki T, Haraoka J, Okubo M, Sugahara S, Tokuuye K, Preliminary Results of Fractionated Stereotactic Radiotherapy After Cyst Drainage for Craniopharyngioma in Adults. International Journal of Radiation Oncology*Biology*Physics. 2012;82 (4):1356–1360.CrossRefGoogle Scholar
  23. Kilday J-P, Caldarelli M, Massimi L, Chen RH-H, Lee YY, Liang M-L, Parkes J, Naiker T, van Veelen M-L, Michiels E, et al. Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN. Neuro-Oncology. 2017;19:1398–407.CrossRefPubMedGoogle Scholar
  24. Kim MS, Kim YS, Lee HK, Lee GJ, Choi CY, Lee CH. Primary intracranial ectopic craniopharyngioma in a patient with probable Gardner’s syndrome. J Neurosurg. 2014;120:337–41.CrossRefPubMedGoogle Scholar
  25. Koral K, Weprin B, Rollins NK. Sphenoid sinus craniopharyngioma simulating mucocele. Acta Radiol. 2006;1987(47):494–6.CrossRefGoogle Scholar
  26. Lamiman K, Wong KK, Tamrazi B, Nosrati JD, Olch A, Chang EL, Kiehna EN. A quantitative analysis of craniopharyngioma cyst expansion during and after radiation therapy and surgical implications. Neurosurg Focus. 2016;41:E15.CrossRefPubMedGoogle Scholar
  27. Larkin SJ, Preda V, Karavitaki N, Grossman A, Ansorge O. BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma. Acta Neuropathol. 2014;127:927–9.CrossRefPubMedPubMedCentralGoogle Scholar
  28. Leber KA, Berglöff J, Pendl G. Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg. 1998;88:43–50.CrossRefPubMedGoogle Scholar
  29. Lin LL, El Naqa I, Leonard JR, Park TS, Hollander AS, Michalski JM, Mansur DB. Long-term outcome in children treated for craniopharyngioma with and without radiotherapy. J Neurosurg Pediatr. 2008;1:126–30.CrossRefPubMedGoogle Scholar
  30. Lo AC, Fuchsia Howard A, Nichol A, Hasan H, Martin M, Heran M, Goddard K, A Cross-Sectional Cohort Study of Cerebrovascular Disease and Late Effects After Radiation Therapy for Craniopharyngioma. Pediatric Blood & Cancer. 2016;63 (5):786–793.CrossRefGoogle Scholar
  31. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO classification of tumours of the central nervous system. 2016, 4rth Edition, Volume 1 Google Scholar
  32. Luu QT, Loredo LN, Archambeau JO, Yonemoto LT, Slater JM, Slater JD. Fractionated proton radiation treatment for pediatric craniopharyngioma: preliminary report. Cancer J. 2006;12:155–9.PubMedGoogle Scholar
  33. Mayo C, Martel MK, Marks LB, Flickinger J, Nam J, Kirkpatrick J. Radiation dose-volume effects of optic nerves and chiasm. Int J Radiat Oncol Biol Phys. 2010;76:S28–35.CrossRefPubMedGoogle Scholar
  34. Merchant TE, Kiehna EN, Kun LE, Mulhern RK, Li C, Xiong X, Boop FA, Sanford RA. Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. J Neurosurg. 2006;104:94–102.PubMedGoogle Scholar
  35. Merchant TE, Hua C-H, Shukla H, Ying X, Nill S, Oelfke U. Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function. Pediatr Blood Cancer. 2008;51:110–7.CrossRefPubMedGoogle Scholar
  36. Merchant TE, Kun LE, Hua C-H, Wu S, Xiong X, Sanford RA, Boop FA. Disease control after reduced volume conformal and intensity modulated radiation therapy for childhood craniopharyngioma. Int J Radiat Oncol Biol Phys. 2013;85:e187–92.CrossRefPubMedGoogle Scholar
  37. Minniti G, Saran F, Traish D, Soomal R, Sardell S, Gonsalves A, Ashley S, Warrington J, Burke K, Mosleh-Shirazi A, Brada M, Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas. Radiotherapy and Oncology. 2007;82 (1):90–95.CrossRefPubMedGoogle Scholar
  38. Minniti G, Esposito V, Amichetti M, Enrici RM. The role of fractionated radiotherapy and radiosurgery in the management of patients with craniopharyngioma. Neurosurg Rev. 2009;32:125–32; discussion 132.CrossRefPubMedGoogle Scholar
  39. Minniti G, Traish D, Ashley S, Gonsalves A, Brada M. Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. J Clin Endocrinol Metab. 2005;90:800–4.CrossRefPubMedGoogle Scholar
  40. Moon SH, Kim IH, Park SW, Kim I, Hong S, Park CI, Wang KC, Cho BK. Early adjuvant radiotherapy toward long-term survival and better quality of life for craniopharyngiomas–a study in single institute. Childs Nerv Syst. 2005;21:799–807.CrossRefPubMedGoogle Scholar
  41. Nielsen EH, Feldt-Rasmussen U, Poulsgaard L, Kristensen LO, Astrup J, Jørgensen JO, Bjerre P, Andersen M, Andersen C, Jørgensen J, et al. Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults. J Neuro-Oncol. 2011;104:755–63.CrossRefGoogle Scholar
  42. Pemberton LS, Dougal M, Magee B, Gattamaneni HR. Experience of external beam radiotherapy given adjuvantly or at relapse following surgery for craniopharyngioma. Radiother Oncol. 2005;77:99–104.CrossRefPubMedGoogle Scholar
  43. Rostami E, Witt Nyström P, Libard S, Wikström J, Casar-Borota O, Gudjonsson O. Recurrent papillary craniopharyngioma with BRAFV600E mutation treated with neoadjuvant-targeted therapy. Acta Neurochir. 2017;159:2217–21.CrossRefPubMedGoogle Scholar
  44. Sartoretti-Schefer S, Wichmann W, Aguzzi A, Valavanis A. MR differentiation of adamantinous and squamous-papillary craniopharyngiomas. AJNR Am J Neuroradiol. 1997;18:77–87.PubMedGoogle Scholar
  45. Schweizer L, Capper D, Hölsken A, Fahlbusch R, Flitsch J, Buchfelder M, Herold-Mende C, von Deimling A, Buslei R, Neuropathology and Applied Neurobiology. 2015;41 (6):733–742.CrossRefGoogle Scholar
  46. Shi Z, Esiashvili N, Janss AJ, Mazewski CM, MacDonald TJ, Wrubel DM, Brahma B, Schwaibold FP, Marcus RB, Crocker IR, et al. Transient enlargement of craniopharyngioma after radiation therapy: pattern of magnetic resonance imaging response following radiation. J Neuro-Oncol. 2012;109:349–55.CrossRefGoogle Scholar
  47. Stephen F. Kralik, Gordon A. Watson, Chie-Schin Shih, Chang Y. Ho, Whitney Finke, Jeffrey Buchsbaum, Radiation-Induced Large Vessel Cerebral Vasculopathy in Pediatric Patients With Brain Tumors Treated With Proton Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 2017;99 (4):817–824.CrossRefGoogle Scholar
  48. Sterkenburg AS, Hoffmann A, Gebhardt U, Warmuth-Metz M, Daubenbüchel AMM, Müller HL. Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neuro-Oncology. 2015;17:1029–38.CrossRefPubMedPubMedCentralGoogle Scholar
  49. Stripp DCH, Maity A, Janss AJ, Belasco JB, Tochner ZA, Goldwein JW, Moshang T, Rorke LB, Phillips PC, Sutton LN, et al. Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults. Int J Radiat Oncol Biol Phys. 2004;58:714–20.CrossRefPubMedGoogle Scholar
  50. Thomsett MJ, Conte FA, Kaplan SL, Grumbach MM. Endocrine and neurologic outcome in childhood craniopharyngioma: review of effect of treatment in 42 patients. J Pediatr. 1980;97:728–35.CrossRefPubMedGoogle Scholar
  51. Tishler RB, Loeffler JS, Lunsford LD, Duma C, Alexander E, Kooy HM, Flickinger JC. Tolerance of cranial nerves of the cavernous sinus to radiosurgery. Int J Radiat Oncol Biol Phys. 1993;27:215–21.CrossRefPubMedGoogle Scholar
  52. Tomita T, Bowman RM. Craniopharyngiomas in children: surgical experience at Children’s Memorial Hospital. Childs Nerv Syst. 2005;21:729–46.CrossRefPubMedGoogle Scholar
  53. Van Effenterre R, Boch A-L. Craniopharyngioma in adults and children: a study of 122 surgical cases. J Neurosurg. 2002;97:3–11.CrossRefPubMedGoogle Scholar
  54. Vanhauwaert D, Hallaert G, Baert E, Van Roost D, Okito J-PK, Caemaert J. Treatment of cystic craniopharyngioma by endocavitary instillation of yttrium90 radioisotope–still a valuable treatment option. J Neurol Surg Part Cent Eur Neurosurg. 2013;74:307–12.CrossRefGoogle Scholar
  55. Varlotto JM, Flickinger JC, Kondziolka D, Lunsford LD, Deutsch M. External beam irradiation of craniopharyngiomas: long-term analysis of tumor control and morbidity. Int J Radiat Oncol Biol Phys. 2002;54:492–9.CrossRefPubMedGoogle Scholar
  56. Wijnen M, van den Heuvel-Eibrink MM, Janssen JAMJL, Catsman-Berrevoets CE, Michiels EMC, van Veelen-Vincent M-LC, Dallenga AHG, van den Berge JH, van Rij CM, van der Lely A-J, et al. Very long-term sequelae of craniopharyngioma. Eur J Endocrinol. 2017;176:755–67.CrossRefPubMedGoogle Scholar
  57. Winkfield KM, Linsenmeier C, Yock TI, Grant PE, Yeap BY, Butler WE, Tarbell NJ. Surveillance of craniopharyngioma cyst growth in children treated with proton radiotherapy. Int J Radiat Oncol Biol Phys. 2009;73:716–21.CrossRefPubMedGoogle Scholar
  58. Yu X, Zhang J, Liu R, Wang Y, Wang H, Wang P, Chen J, Liu S. Interstitial radiotherapy using phosphorus-32 for giant posterior fossa cystic craniopharyngiomas. J Neurosurg Pediatr. 2015;15:510–8.CrossRefPubMedGoogle Scholar
  59. Zacharia BE, Bruce SS, Goldstein H, Malone HR, Neugut AI, Bruce JN. Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program. Neuro-Oncology. 2012;14:1070–8.CrossRefPubMedPubMedCentralGoogle Scholar
  60. Zhang Y-Q, Wang C-C, Ma Z-Y. Pediatric craniopharyngiomas: clinicomorphological study of 189 cases. Pediatr Neurosurg. 2002;36:80–4.CrossRefPubMedGoogle Scholar
  61. Zhang S, Fang Y, Cai BW, Xu JG, You C. Intracystic bleomycin for cystic craniopharyngiomas in children. Cochrane Database Syst Rev. 2016;7:CD008890.PubMedGoogle Scholar
  62. Zhang C, Verma V, Lyden ER, Horowitz DP, Zacharia BE, Lin C, Connolly EP. The role of definitive radiotherapy in craniopharyngioma: a SEER analysis. Am J Clin Oncol. 2017;0:1–6Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Universität LeipzigLeipzigGermany
  2. 2.Department of Neurosurgery, Universitätsklinikum LeipzigLeipzigGermany
  3. 3.Department of Radiotherapy and Radiation-Oncology, Universitätsklinikum LeipzigLeipzigGermany

Personalised recommendations